DOCSLIB.ORG

Mouse Zmym2 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Zmym2 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Zmym2 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Zmym2 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Zmym2 gene (NCBI Reference Sequence: NM_029498 ; Ensembl: ENSMUSG00000021945 ) is located on Mouse chromosome 14. 24 exons are identified, with the ATG start codon in exon 2 and the TAA stop codon in exon 24 (Transcript: ENSMUST00000022511). Exon 4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Zmym2 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-83G22 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for an ENU-induced mutation exhibit prenatal lethality. Exon 4 starts from about 27.4% of the coding region. The knockout of Exon 4 will result in frameshift of the gene. The size of intron 3 for 5'-loxP site insertion: 1591 bp, and the size of intron 4 for 3'-loxP site insertion: 838 bp. The size of effective cKO region: ~666 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 4 5 24 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Zmym2 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. It may be difficult to construct this targeting vector. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7166bp) | A(26.89% 1927) | C(16.49% 1182) | T(37.44% 2683) | G(19.17% 1374) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr14 + 56909703 56912702 3000 browser details YourSeq 280 1362 1663 3000 96.4% chr14 - 56798905 56799206 302 browser details YourSeq 263 422 1103 3000 89.1% chr1 + 167296442 167297188 747 browser details YourSeq 262 766 1103 3000 89.5% chr11 + 78869325 79226444 357120 browser details YourSeq 230 811 1103 3000 90.9% chr10 + 127315000 127325389 10390 browser details YourSeq 210 1375 1666 3000 87.8% chr8 + 21237168 21237462 295 browser details YourSeq 210 1375 1666 3000 87.8% chr8 + 21101145 21101439 295 browser details YourSeq 206 1375 1666 3000 87.1% chr8 + 21599399 21599693 295 browser details YourSeq 204 1375 1666 3000 86.7% chr8 + 21461452 21461746 295 browser details YourSeq 203 812 1103 3000 85.1% chr11 - 60824289 60824570 282 browser details YourSeq 196 772 1103 3000 89.9% chr2 - 150781411 150782049 639 browser details YourSeq 192 812 1089 3000 85.9% chr10 - 117460780 117461046 267 browser details YourSeq 191 1375 1619 3000 91.0% chr8 + 21708525 21708775 251 browser details YourSeq 190 812 1096 3000 90.0% chr11 + 110388338 110388737 400 browser details YourSeq 189 1375 1619 3000 90.6% chr8 + 21331442 21331692 251 browser details YourSeq 187 815 1103 3000 88.5% chr8 + 104289395 104289917 523 browser details YourSeq 170 842 1103 3000 91.7% chr11 - 61114924 61115281 358 browser details YourSeq 166 741 1103 3000 84.5% chr19 - 53111395 53111651 257 browser details YourSeq 160 812 1103 3000 91.7% chr13 - 104088239 104088765 527 browser details YourSeq 160 812 1091 3000 83.6% chr1 - 59618373 59618601 229 Note: The 3000 bp section upstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr14 + 56913369 56916368 3000 browser details YourSeq 146 1 1534 3000 94.0% chr11 + 98735599 99233767 498169 browser details YourSeq 123 1452 1616 3000 88.4% chr10 + 127221946 127222109 164 browser details YourSeq 114 1462 1630 3000 84.9% chr4 - 139079350 139079515 166 browser details YourSeq 110 1454 1587 3000 91.1% chr17 + 51732953 51733086 134 browser details YourSeq 109 1445 1619 3000 84.7% chr2 + 132461561 132461796 236 browser details YourSeq 105 1454 1631 3000 90.7% chr1 + 59881226 59881419 194 browser details YourSeq 102 1452 1578 3000 92.5% chr11 - 62528268 62528730 463 browser details YourSeq 99 1475 1587 3000 92.0% chr12 - 33163686 33163797 112 browser details YourSeq 99 1456 1591 3000 86.7% chr13 + 17774856 17775001 146 browser details YourSeq 97 1450 1582 3000 86.5% chr4 + 135201320 135201452 133 browser details YourSeq 95 1448 1571 3000 88.8% chr9 - 56906557 56906681 125 browser details YourSeq 95 1452 1576 3000 88.0% chr10 - 32814508 32814632 125 browser details YourSeq 93 1459 1573 3000 90.5% chr16 - 29785318 29785432 115 browser details YourSeq 93 1452 1578 3000 86.7% chr16 - 8503685 8503811 127 browser details YourSeq 93 1471 1587 3000 89.8% chr5 + 147642216 147642332 117 browser details YourSeq 92 1452 1582 3000 83.6% chr11 - 57541486 57541614 129 browser details YourSeq 92 1456 1582 3000 86.7% chr10 + 21127356 21127486 131 browser details YourSeq 91 1448 1574 3000 83.2% chr14 + 30983294 30983418 125 browser details YourSeq 90 1458 1578 3000 88.4% chr10 + 95286695 95286814 120 Note: The 3000 bp section downstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Zmym2 zinc finger, MYM-type 2 [ Mus musculus (house mouse) ] Gene ID: 76007, updated on 24-Oct-2019 Gene summary Official Symbol Zmym2 provided by MGI Official Full Name zinc finger, MYM-type 2 provided by MGI Primary source MGI:MGI:1923257 See related Ensembl:ENSMUSG00000021945 Gene type protein coding RefSeq status REVIEWED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as FIM; MYM; RAMP; SCLL; Zfp198; Znf198; 5830413P05Rik Summary This gene encodes a protein that contains nine MYM-type zinc finger motifs. Expression of this gene may mediate the Expression inhibition of hematopoietic cell development during ontogeny, and the encoded protein may also play a role in transforming growth factor-beta signaling as a Smad binding protein. [provided by RefSeq, Feb 2011] Orthologs Broad expression in CNS E11.5 (RPKM 12.5), CNS E14 (RPKM 11.4) and 25 other tissues See more human all Genomic context Location: 14; 14 C3 See Zmym2 in Genome Data Viewer Exon count: 27 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 14 NC_000080.6 (56886529..56962358) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 14 NC_000080.5 (57506631..57579186) Chromosome 14 - NC_000080.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 7 transcripts Gene: Zmym2 ENSMUSG00000021945 Description zinc finger, MYM-type 2 [Source:MGI Symbol;Acc:MGI:1923257] Gene Synonyms FIM, MYM, RAMP, SCLL, Zfp198 Location Chromosome 14: 56,886,653-56,962,701 forward strand. GRCm38:CM001007.2 About this gene This gene has 7 transcripts (splice variants), 203 orthologues, 13 paralogues, is a member of 1 Ensembl protein family and is associated with 1 phenotype. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Zmym2-201 ENSMUST00000022511.9 6974 1376aa ENSMUSP00000022511.8 Protein coding CCDS49506 Q9CU65 TSL:1 GENCODE basic APPRIS P1 Zmym2-202 ENSMUST00000223669.1 1281 290aa ENSMUSP00000152925.1 Protein coding - A0A286YCD5 GENCODE basic Zmym2-203 ENSMUST00000223965.1 772 No protein - Retained intron - - - Zmym2-207 ENSMUST00000226025.1 607 No protein - Retained intron - - - Zmym2-206 ENSMUST00000225393.1 332 No protein - Retained intron - - - Zmym2-204 ENSMUST00000224922.1 2829 No protein - lncRNA - - - Zmym2-205 ENSMUST00000225282.1 741 No protein - lncRNA - - - 96.05 kb Forward strand 56.88Mb 56.90Mb 56.92Mb 56.94Mb 56.96Mb Genes (Comprehensive set... Zmym2-202 >protein coding Zmym2-204 >lncRNA Zmym2-201 >protein coding Zmym2-206 >retained intron Zmym2-205 >lncRNAZmym2-203 >retained intron Zmym2-207 >retained intron Contigs < AC154361.2 < AC154303.2 Regulatory Build 56.88Mb 56.90Mb 56.92Mb 56.94Mb 56.96Mb Reverse strand 96.05 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript RNA gene Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000022511 74.88 kb Forward strand Zmym2-201 >protein coding ENSMUSP00000022... MobiDB lite Low complexity (Seg) Superfamily SSF57716 SMART TRASH domain Pfam Zinc finger, MYM-type Protein of unknown function DUF3504 PANTHER PTHR45736 PTHR45736:SF6 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 200 400 600 800 1000 1376 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Screen for Multi-SUMO–Binding Proteins Reveals a Multi-SIM–Binding Mechanism for Recruitment of the Transcriptional Regulator ZMYM2 to Chromatin
    Screen for multi-SUMO–binding proteins reveals a multi-SIM–binding mechanism for recruitment of the transcriptional regulator ZMYM2 to chromatin Elisa Aguilar-Martineza, Xi Chena, Aaron Webbera, A. Paul Moulda, Anne Seifertb, Ronald T. Hayb, and Andrew D. Sharrocksa,1 aFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and bCentre for Gene Regulation and Expression, University of Dundee, Dundee DD1 5EH, United Kingdom Edited by James L. Manley, Columbia University, New York, NY, and approved July 17, 2015 (received for review May 20, 2015) Protein SUMOylation has emerged as an important regulatory human proteins containing two or more motifs corresponding event, particularly in nuclear processes such as transcriptional to the extended negatively charged amino acid-dependent control and DNA repair. In this context, small ubiquitin-like modifier SUMOylation motif (NDSM) (13) Thus, there is a huge poten- (SUMO) often provides a binding platform for the recruitment of tial for widespread multi-SUMOylation of proteins to occur. proteins via their SUMO-interacting motifs (SIMs). Recent discoveries Indeed, several of these proteins have been shown to be point to an important role for multivalent SUMO binding through SUMOylated on multiple sites, including megakaryoblastic leu- multiple SIMs in the binding partner as exemplified by poly- kemia (translocation) 1 (MKL1) (14), CREB-binding protein SUMOylation acting as a binding platform for ubiquitin E3 ligases (CBP) (15), and PEA3/ETV4 (16). Furthermore, two recent such as ring finger protein 4. Here, we have investigated whether proteomic studies emphasize the potential for more widespread other types of protein are recruited through multivalent SUMO multi-SUMOylation as they found that a large proportion of all interactions.
    [Show full text]
  • T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia
    cancers Article T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker Magda Zanelli 1 , Giuseppe G. Loscocco 2,3 , Elena Sabattini 4, Maurizio Zizzo 5,6,* , Francesca Sanguedolce 7, Luigi Panico 8, Daniela Fanni 9, Raffaella Santi 10, Cecilia Caprera 11, Cristiana Rossi 12, Alessandra Soriano 13,14, Alberto Cavazza 1, Alessandro Giunta 5, Cristina Mecucci 15, Alessandro M. Vannucchi 2,3, Stefano A. Pileri 16 and Stefano Ascani 11,15 1 Pathology Unit, Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy; [email protected] (M.Z.); [email protected] (A.C.) 2 Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy; gloscocco@unifi.it (G.G.L.); a.vannucchi@unifi.it (A.M.V.) 3 Center of Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Azienda Ospedaliero-Universitaria Careggi, 50139 Florence, Italy 4 Citation: Zanelli, M.; Loscocco, G.G.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy; Sabattini, E.; Zizzo, M.; [email protected] 5 Sanguedolce, F.; Panico, L.; Fanni, D.; Surgical Oncology Unit, Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy; [email protected] Santi, R.; Caprera, C.; Rossi, C.; et al. 6 Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, T-Cell Lymphoblastic Lymphoma 41121 Modena, Italy Arising in the Setting of 7 Pathology Unit, Azienda Ospedaliero-Universitaria—Ospedali Riuniti di Foggia, 71122 Foggia, Italy; Myeloid/Lymphoid Neoplasms with [email protected] Eosinophilia: LMO2 8 Pathology Unit Azienda Ospedaliera dei Colli Monaldi-Cotugno-CTO, P.O.
    [Show full text]
  • Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham a Thesis Submitted in Conformity
    Characterizing Genomic Duplication in Autism Spectrum Disorder by Edward James Higginbotham A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department of Molecular Genetics University of Toronto © Copyright by Edward James Higginbotham 2020 i Abstract Characterizing Genomic Duplication in Autism Spectrum Disorder Edward James Higginbotham Master of Science Graduate Department of Molecular Genetics University of Toronto 2020 Duplication, the gain of additional copies of genomic material relative to its ancestral diploid state is yet to achieve full appreciation for its role in human traits and disease. Challenges include accurately genotyping, annotating, and characterizing the properties of duplications, and resolving duplication mechanisms. Whole genome sequencing, in principle, should enable accurate detection of duplications in a single experiment. This thesis makes use of the technology to catalogue disease relevant duplications in the genomes of 2,739 individuals with Autism Spectrum Disorder (ASD) who enrolled in the Autism Speaks MSSNG Project. Fine-mapping the breakpoint junctions of 259 ASD-relevant duplications identified 34 (13.1%) variants with complex genomic structures as well as tandem (193/259, 74.5%) and NAHR- mediated (6/259, 2.3%) duplications. As whole genome sequencing-based studies expand in scale and reach, a continued focus on generating high-quality, standardized duplication data will be prerequisite to addressing their associated biological mechanisms. ii Acknowledgements I thank Dr. Stephen Scherer for his leadership par excellence, his generosity, and for giving me a chance. I am grateful for his investment and the opportunities afforded me, from which I have learned and benefited. I would next thank Drs.
    [Show full text]
  • Identification of Disease Gene Variants That Can Lead to Familial Myelodysplasia and Acute Myeloid Leukaemia
    Identification of disease gene variants that can lead to familial myelodysplasia and acute myeloid leukaemia A thesis submitted for the degree of PhD Shirleny Romualdo Cardoso Supervisors: Professor Inderjeet Dokal, and Professor Tom Vulliamy Centre for Genomics and Child Health, Blizard Institute Barts and The London School of Medicine & Dentistry, Queen Mary University of London In loving memory of my beloved sister Karla Romualdo Cardoso 2 I, Shirleny Romualdo Cardoso, confirm that the research included within this thesis is my own work or that where it has been carried out in collaboration with, or supported by others, that this is duly acknowledged below and my contribution indicated. Previously published material is also acknowledged below. I attest that I have exercised reasonable care to ensure that the work is original, and does not to the best of my knowledge break any UK law, infringe any third party’s copyright or other Intellectual Property Right, or contain any confidential material. I accept that the College has the right to use plagiarism detection software to check the electronic version of the thesis. I confirm that this thesis has not been previously submitted for the award of a degree by this or any other university. The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. Shirleny Romualdo Cardoso 3 Abstract Myelodysplasia (MDS) is characterised by inefficient haematopoiesis with dysplastic features of blood and bone marrow, reduction of mature blood cells and continuous bone marrow failure (BMF).
    [Show full text]
  • Cancer Drug Resistance
    Cowell et al. Cancer Drug Resist 2021;4:607-19 Cancer DOI: 10.20517/cdr.2021.30 Drug Resistance Review Open Access Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment John K. Cowell, Tianxiang Hu Georgia Cancer Center, 1410 Laney Walker Blvd, Augusta, GA 30912, USA. Correspondence to: Prof. John K. Cowell, CN2133, Georgia Cancer Center, 1410 Laney Walker Blvd, Augusta, GA 30912, USA. E- mail: [email protected] How to cite this article: Cowell JK, Hu T. Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment. Cancer Drug Resist 2021;4:607-19. https://dx.doi.org/10.20517/cdr.2021.30 Received: 6 Apr 2021 First Decision: 28 Apr 2021 Revised: 14 May 2021 Accepted: 24 May 2021 First online: 25 May 2021 Academic Editor: Godefridus J. Peters Copy Editor: Yue-Yue Zhang Production Editor: Yue-Yue Zhang Abstract Myeloid and lymphoid neoplasms with eosinophilia and FGFR1 rearrangements (MLN-eo FGFR1) disease is derived from a pluripotent hematopoietic stem cell and has a complex presentation with a myeloproliferative disorder with or without eosinophilia and frequently presents with mixed lineage T- or B-lymphomas. The myeloproliferative disease frequently progresses to AML and lymphoid neoplasms can develop into acute lymphomas. No matter the cell type involved, or clinical presentation, chromosome translocations involving the FGFR1 kinase and various partner genes, which leads to constitutive activation of downstream oncogenic signaling cascades. These patients are not responsive to treatment regimens developed for other acute leukemias and survival is poor.
    [Show full text]
  • ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing
    RESEARCH ARTICLE ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing Ellen M. Beauchamp1,2, Matthew Leventhal1,2, Elsa Bernard3, Emma R. Hoppe4,5,6, Gabriele Todisco7,8, Maria Creignou8, Anna Gallì7, Cecilia A. Castellano1,2, Marie McConkey1,2, Akansha Tarun1,2, Waihay Wong1,2, Monica Schenone2, Caroline Stanclift2, Benjamin Tanenbaum2, Edyta Malolepsza2, Björn Nilsson1,2,9, Alexander G. Bick2,10,11, Joshua S. Weinstock12, Mendy Miller2, Abhishek Niroula1,2, Andrew Dunford2, Amaro Taylor-Weiner2, Timothy Wood2, Alex Barbera2, Shankara Anand2; Bruce M. Psaty13,14, Pinkal Desai15, Michael H. Cho16,17, Andrew D. Johnson18, Ruth Loos19,20; for the NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Daniel G. MacArthur2,21,22,23, Monkol Lek2,21,24; for the Exome Aggregation Consortium, Donna S. Neuberg25, Kasper Lage2,26, Steven A. Carr2, Eva Hellstrom-Lindberg8, Luca Malcovati7, Elli Papaemmanuil3, Chip Stewart2, Gad Getz2,27,28, Robert K. Bradley4,5,6, Siddhartha Jaiswal29, and Benjamin L. Ebert1,2,30 Downloaded from https://bloodcancerdiscov.aacrjournals.org by guest on September 30, 2021. Copyright 2021 American Copyright 2021 by AssociationAmerican for Association Cancer Research. for Cancer Research. ABSTRACT Clonal hematopoiesis results from somatic mutations in cancer driver genes in hematopoietic stem cells. We sought to identify novel drivers of clonal expansion using an unbiased analysis of sequencing data from 84,683 persons and identified common mutations in the 5-methylcytosine reader ZBTB33 as well as in YLPM1, SRCAP, and ZNF318. We also identified these mutations at low frequency in patients with myelodysplastic syndrome. Zbtb33-edited mouse hematopoietic stem and progenitor cells exhibited a competitive advantage in vivo and increased genome-wide intron retention.
    [Show full text]
  • A Global Transcriptional Network Connecting Noncoding Mutations to Changes in Tumor Gene Expression
    ARTICLES https://doi.org/10.1038/s41588-018-0091-2 A global transcriptional network connecting noncoding mutations to changes in tumor gene expression Wei Zhang 1,8*, Ana Bojorquez-Gomez1,8, Daniel Ortiz Velez2, Guorong Xu3, Kyle S. Sanchez1, John Paul Shen 1, Kevin Chen2, Katherine Licon1, Collin Melton4, Katrina M. Olson1,5, Michael Ku Yu1, Justin K. Huang1,6, Hannah Carter 1, Emma K. Farley1,5, Michael Snyder4, Stephanie I. Fraley2, Jason F. Kreisberg1* and Trey Ideker 1,2,6,7* Although cancer genomes are replete with noncoding mutations, the effects of these mutations remain poorly characterized. Here we perform an integrative analysis of 930 tumor whole genomes and matched transcriptomes, identifying a network of 193 noncoding loci in which mutations disrupt target gene expression. These ‘somatic eQTLs’ (expression quantitative trait loci) are frequently mutated in specific cancer tissues, and the majority can be validated in an independent cohort of 3,382 tumors. Among these, we find that the effects of noncoding mutations on DAAM1, MTG2 and HYI transcription are recapitu- lated in multiple cancer cell lines and that increasing DAAM1 expression leads to invasive cell migration. Collectively, the non- coding loci converge on a set of core pathways, permitting a classification of tumors into pathway-based subtypes. The somatic eQTL network is disrupted in 88% of tumors, suggesting widespread impact of noncoding mutations in cancer. uman cancers are fundamentally heterogeneous, with many Results distinct subtypes associated with differences
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • 8P11 Myeloproliferative Syndrome
    8p11 myeloproliferative syndrome Description 8p11 myeloproliferative syndrome is a blood cancer that involves different types of blood cells. Blood cells are divided into several groups (lineages) based on the type of early cell from which they are descended. Two of these lineages are myeloid cells and lymphoid cells. Individuals with 8p11 myeloproliferative syndrome can develop both myeloid cell cancer and lymphoid cell cancer. The condition can occur at any age. It usually begins as a myeloproliferative disorder, which is characterized by a high number of white blood cells (leukocytes). Most affected individuals also have an excess of myeloid cells known as eosinophils (eosinophilia). In addition to a myeloproliferative disorder, many people with 8p11 myeloproliferative syndrome develop lymphoma, which is a form of blood cancer that involves lymphoid cells. The cancerous lymphoid cells grow and divide in lymph nodes, forming a tumor that enlarges the lymph nodes. In most cases of 8p11 myeloproliferative syndrome, the cancerous cells are lymphoid cells called T cells. Lymphoma can develop at the same time as the myeloproliferative disorder or later. In most people with 8p11 myeloproliferative syndrome, the myeloproliferative disorder develops into a fast-growing blood cancer called acute myeloid leukemia. The rapid myeloid and lymphoid cell production caused by these cancers results in enlargement of the spleen and liver (splenomegaly and hepatomegaly, respectively). Most people with 8p11 myeloproliferative syndrome have symptoms such as fatigue or night sweats. Some affected individuals have no symptoms, and the condition is discovered through routine blood tests. Frequency The prevalence of 8p11 myeloproliferative syndrome is unknown. It is thought to be a rare condition.
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]
  • Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations
    ARTICLE Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations Dervla M. Connaughton,1,2,46 Rufeng Dai,1,3,46 Danielle J. Owen,4 Jonathan Marquez,5 Nina Mann,1 Adda L. Graham-Paquin,6 Makiko Nakayama,1 Etienne Coyaud,7,8 Estelle M.N. Laurent,7,8 Jonathan R. St-Germain,7 Lot Snijders Blok,9,10,11 Arianna Vino,9 Verena Kla¨mbt,1 Konstantin Deutsch,1 Chen-Han Wilfred Wu,1 Caroline M. Kolvenbach,1 Franziska Kause,1 Isabel Ottlewski,1 Ronen Schneider,1 Thomas M. Kitzler,1 Amar J. Majmundar,1 Florian Buerger,1 Ana C. Onuchic-Whitford,1,12 Mao Youying,1 Amy Kolb,1 Daanya Salmanullah,1 Evan Chen,1 Amelie T. van der Ven,1 Jia Rao,3 Hadas Ityel,1 Steve Seltzsam,1 Johanna M. Rieke,1 Jing Chen,1 Asaf Vivante,1,13 Daw-Yang Hwang,1 Stefan Kohl,1 Gabriel C. Dworschak,1 (Author list continued on next page) Summary Congenital anomalies of the kidney and urinary tract (CAKUT) constitute one of the most frequent birth defects and represent the most common cause of chronic kidney disease in the first three decades of life. Despite the discovery of dozens of monogenic causes of CA- KUT, most pathogenic pathways remain elusive. We performed whole-exome sequencing (WES) in 551 individuals with CAKUT and identified a heterozygous de novo stop-gain variant in ZMYM2 in two different families with CAKUT. Through collaboration, we identi- fied in total 14 different heterozygous loss-of-function mutations in ZMYM2 in 15 unrelated families.
    [Show full text]